Acumen Pharmaceuticals In... (ABOS)

1.16

-0.12 (-9.38%)

At close: Mar 03, 2025, 3:59 PM

1.15

-0.86%

After-hours: Mar 03, 2025, 04:00 PM EST

Acumen Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-52.37M	-42.86M	-100.61M	-7.33M	-7.91M
Depreciation & Amortization	184K	169K	4K	n/a	n/a
Stock-Based Compensation	6.14M	3.06M	922K	154K	174K
Other Working Capital	4.13M	3.43M	-259K	-1K	658K
Other Non-Cash Items	-888K	487K	81.27M	-586K	147K
Deferred Income Tax	n/a	n/a	155K	n/a	n/a
Change in Working Capital	3.87M	3.99M	298K	307K	768K
Operating Cash Flow	-43.06M	-35.15M	-17.96M	-7.45M	-6.82M
Capital Expenditures	-21K	-161K	-40K	n/a	n/a
Acquisitions	n/a	-39.35K	n/a	n/a	n/a
Purchase of Investments	-250.63M	-41.51M	-104.08M	n/a	n/a
Sales Maturities Of Investments	78.98M	80.86M	n/a	n/a	n/a
Other Investing Acitivies	3K	39.35K	-104.08K	n/a	n/a
Investing Cash Flow	-171.67M	39.19M	-104.12M	n/a	n/a
Debt Repayment	30M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-151K	115K	31.91M	44.67M	6.24M
Financial Cash Flow	151.75M	3.91M	200.47M	44.67M	6.24M
Net Cash Flow	-62.98M	7.94M	78.39M	37.23M	-579K
Free Cash Flow	-43.09M	-35.31M	-18M	-7.45M	-6.82M